Genetic predisposition syndromes: When should they be considered in the work-up of MDS?

Best Practice and Research: Clinical Haematology

Volumn 28, Issue 1, 2015, Pages 55-68

  Babushok, Daria V ^a,b   Bessler, Monica ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

bone marrow failure syndromes; CEBPA; Congenital Amegakaryocytic; Diamond Blackfan Anemia; Dyskeratosis Congenita; Emberger Syndrome; familial leukemia; Fanconi Anemia; FPD AML; GATA2; genetic predisposition familial; Keywords myelodysplastic syndromes; MDS; MonoMac; RUNX1; Severe Congenital Neutropenia; Shwachman Diamond Syndrome; SRP72; Thrombocytopenia

Indexed keywords

TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR RUNX1; ANTINEOPLASTIC AGENT; CCAAT ENHANCER BINDING PROTEIN; CEBPA PROTEIN, HUMAN; GATA2 PROTEIN, HUMAN; RUNX1 PROTEIN, HUMAN; SIGNAL RECOGNITION PARTICLE; SRP72 PROTEIN, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLACKFAN DIAMOND ANEMIA; BONE MARROW DEPRESSION; CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HAPLOINSUFFICIENCY; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SEVERE CONGENITAL NEUTROPENIA; SHWACHMAN SYNDROME; THROMBOCYTE; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; TRANSCRIPTION FACTOR GATA 2 HAPLOINSUFFICIENCY SYNDROME; ADOLESCENT; AGED; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LEUKEMIA, MYELOID, ACUTE; MUTATION; MYELODYSPLASTIC SYNDROMES; PATHOLOGY;

ADOLESCENT; AGED; ANTINEOPLASTIC AGENTS; CCAAT-ENHANCER-BINDING PROTEINS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DYSKERATOSIS CONGENITA; FANCONI ANEMIA; GATA2 TRANSCRIPTION FACTOR; GENETIC PREDISPOSITION TO DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MUTATION; MYELODYSPLASTIC SYNDROMES; SIGNAL RECOGNITION PARTICLE;

EID: 84922131502     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2014.11.004     Document Type: Review

References (72)

1. S.H. Swerdlow, E. Campo, and N.L. Harris WHO classification of tumours of haematopoietic and lymphoid tissues 2008 IARC Press Lyon, France
2. M. Cazzola, M.G. Della Porta, and L. Malcovati The genetic basis of myelodysplasia and its clinical relevance Blood 122 2013 4021 4034
3. X. Ma, M. Does, and A. Raza Myelodysplastic syndromes: incidence and survival in the United States Cancer 109 2007 1536 1542
4. D.E. Rollison, N. Howlader, and M.T. Smith Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs Blood 112 2008 45 52
5. T. Glaubach, L.J. Robinson, and S.J. Corey Pediatric myelodysplastic syndromes: they do exist! J Pediatr Hematol Oncol 36 2014 1 7
6. M.A. Sekeres The epidemiology of myelodysplastic syndromes Hematol Oncol Clin North Am 24 2010 287 294
7. R. Bejar Prognostic models in myelodysplastic syndromes Hematology Am Soc Hematol Educ Program 2013 2013 504 510
8. P.A. Broliden, I.M. Dahl, and R. Hast Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes Haematologica 91 2006 667 670
9. Z.Y. Lim, S. Killick, and U. Germing Low IPSS score and bone marrow hypocellularity in MDS patients predict hematological responses to antithymocyte globulin Leukemia 21 2007 1436 1441
10. E.M. Sloand, C.O. Wu, and P. Greenberg Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy J Clin Oncol 26 2008 2505 2511
11. J.R. Passweg, A.A. Giagounidis, and M. Simcock Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care-SAKK 33/99 J Clin Oncol 29 2011 303 309
12. M.L. MacMillan, and J.E. Wagner Haematopoeitic cell transplantation for Fanconi anaemia - when and how? Br J Haematol 149 2010 14 21
13. J.E. Vaughn, B.L. Scott, and H.J. Deeg Transplantation for myelodysplastic syndromes 2013 Curr Opin Hematol 20 2013 494 500
14. M. Ayas, A. Nassar, and A.A. Hamidieh Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure Bone Marrow Transplant 48 2013 1168 1172
15. S.M. Gadalla, C. Sales-Bonfim, and J. Carreras Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita Biol Blood Marrow Transplant 19 2013 1238 1243
16. D. Bhatla, S.M. Davies, and S. Shenoy Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome Bone Marrow Transplant 42 2008 159 165
17. P.F. Fogarty, H. Yamaguchi, and A. Wiestner Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA Lancet 362 2003 1628 1630
18. R.F. Orfali, R.F. Wynn, and R.F. Stevens Failure of red cell production following allogenic BMT for Diamond Blackfan anaemia (DBA) illustrates functional significance of high erythrocyte adenosine deaminase (eADA) activity in the donor [abstract] Blood 94 1999 Abstract 414
19. B.P. Alter Cancer in Fanconi anemia, 1927-2001 Cancer 97 2003 425 440
20. B.P. Alter, M.H. Greene, and I. Velazquez Cancer in Fanconi anemia Blood 101 2003 2072
21. B.P. Alter, N. Giri, and S.A. Savage Cancer in dyskeratosis congenita Blood 113 2009 6549 6557
22. A. Zatterale, R. Calzone, and S. Renda Identification and treatment of late onset Fanconi's anemia Haematologica 80 1995 535 538
23. K. Huck, H. Hanenberg, and S. Gudowius Delayed diagnosis and complications of Fanconi anaemia at advanced age-a paradigm Br J Haematol 133 2006 188 197
24. M. Bremer, D. Schindler, and M. Gross Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy Strahlenther Onkol 179 2003 748 753
25. C. Reimann, B. Kloeckener-Gruissem, and C.M. Niemeyer Late manifestation of dyskeratosis congenita presenting as chronic dermal ulcer in a 37-year-old man J Eur Acad Dermatol Venereol 22 2008 897 898
26. K.R. Calvo, D.C. Vinh, and I. Maric Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications Haematologica 96 2011 1221 1225
27. D.C. Vinh, S.Y. Patel, and G. Uzel Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia Blood 115 2010 1519 1529
28. J.B. Powell, I. Dokal, and R. Carr X-linked dyskeratosis congenita presenting in adulthood with photodamaged skin and epiphora Clin Exp Dermatol 39 2014 310 314
29. E.P. Balaban, G.R. Buchanan, and M. Graham Diamond-Blackfan syndrome in adult patients Am J Med 78 1985 533 538
30. T. Pabst, M. Eyholzer, and S. Haefliger Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia J Clin Oncol 26 2008 5088 5093
31. Y. Kee, and A.D. D'Andrea Molecular pathogenesis and clinical management of Fanconi anemia J Clin Invest 122 2012 3799 3806
32. M.C. Kottemann, and A. Smogorzewska Fanconi anaemia and the repair of Watson and Crick DNA crosslinks Nature 493 2013 356 363
33. B.J. Ballew, and S.A. Savage Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders Expert Rev Hematol 6 2013 327 337
34. I. Dokal Dyskeratosis congenita Hematology Am Soc Hematol Educ Program 2011 2011 480 486
35. M. Ballmaier, and M. Germeshausen Congenital amegakaryocytic thrombocytopenia: clinical presentation, diagnosis, and treatment Semin Thromb Hemost 37 2011 673 681
36. A. Vlachos, and E. Muir How I treat Diamond-Blackfan anemia Blood 116 2010 3715 3723
37. K.C. Myers, S.M. Davies, and A. Shimamura Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update Hematol Oncol Clin North Am 27 2013 117 128 [ix]
38. M.S. Horwitz, S.J. Corey, and H.L. Grimes ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology Hematol Oncol Clin North Am 27 2013 19 41 [vii]
39. K. Boztug, and C. Klein Genetics and pathophysiology of severe congenital neutropenia syndromes unrelated to neutrophil elastase Hematol Oncol Clin North Am 27 2013 43 60 [vii]
40. M.A. Spinner, L.A. Sanchez, and A.P. Hsu GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity Blood 123 2014 809 821
41. E.M. Nickels, J. Soodalter, and J.E. Churpek Recognizing familial myeloid leukemia in adults Ther Adv Hematol 4 2013 254 269
42. P.S. Rosenberg, M.H. Greene, and B.P. Alter Cancer incidence in persons with Fanconi anemia Blood 101 2003 822 826
43. S. Quentin, W. Cuccuini, and R. Ceccaldi Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions Blood 117 2011 e161 e170
44. J. Soulier, T. Leblanc, and J. Larghero Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway Blood 105 2005 1329 1336
45. I. Dokal, T. Vulliamy, and P. Mason Clinical utility gene card for: dyskeratosis congenita Eur J Hum Genet 2011 19
46. R.E. Dickinson, P. Milne, and L. Jardine The evolution of cellular deficiency in GATA2 mutation Blood 123 2014 863 874
47. R.R. West, A.P. Hsu, and S.M. Holland Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation Haematologica 99 2014 276 281
48. C.J. Owen, C.L. Toze, and A. Koochin Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy Blood 112 2008 4639 4645
49. M.C. Jongmans, R.P. Kuiper, and C.L. Carmichael Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome Leukemia 24 2010 242 246
50. M. Beri-Dexheimer, V. Latger-Cannard, and C. Philippe Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions Eur J Hum Genet 16 2008 1014 1018
51. C. Preudhomme, A. Renneville, and V. Bourdon High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder Blood 113 2009 5583 5587
52. M.L. Smith, J.D. Cavenagh, and T.A. Lister Mutation of CEBPA in familial acute myeloid leukemia N Engl J Med 351 2004 2403 2407
53. A. Renneville, V. Mialou, and N. Philippe Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation Leukemia 23 2009 804 806
54. M. Kirwan, A.J. Walne, and V. Plagnol Exome sequencing identifies autosomal-dominant SRP72 mutations associated with familial aplasia and myelodysplasia Am J Hum Genet 90 2012 888 892
55. A.J. Walne, A. Dokal, and V. Plagnol Exome sequencing identifies MPL as a causative gene in familial aplastic anemia Haematologica 97 2012 524 528
56. E. Maserati, C. Panarello, and C. Morerio Clonal chromosome anomalies and propensity to myeloid malignancies in congenital amegakaryocytic thrombocytopenia (OMIM 604498) Haematologica 93 2008 1271 1273
57. T.N. Willig, C.M. Niemeyer, and T. Leblanc Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Societe d'Hematologie et d'Immunologie Pediatrique (SHIP), Gesellshaft fur Padiatrische Onkologie und Hamatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI) Pediatr Res 46 1999 553 561
58. V.G. Sankaran, R. Ghazvinian, and R. Do Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia J Clin Invest 122 2012 2439 2443
59. J.H. Fargo, C.P. Kratz, and N. Giri Erythrocyte adenosine deaminase: diagnostic value for Diamond-Blackfan anaemia Br J Haematol 160 2013 547 554
60. A. Vlachos, P.S. Rosenberg, and E. Atsidaftos Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry Blood 119 2012 3815 3819
61. R. Kostmann Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria Acta Paediatr Suppl 45 1956 1 78
62. H.K. Cho, and I.S. Jeon Different clinical phenotypes in familial severe congenital neutropenia cases with same mutation of the ELANE gene J Korean Med Sci 29 2014 452 455
63. P.S. Rosenberg, C. Zeidler, and A.A. Bolyard Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy Br J Haematol 150 2010 196 199
64. P.S. Rosenberg, B.P. Alter, and A.A. Bolyard The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy Blood 107 2006 4628 4635
65. P.S. Rosenberg, B.P. Alter, and D.C. Link Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia Br J Haematol 140 2008 210 213
66. J. Skokowa, D. Steinemann, and J.E. Katsman-Kuipers Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis Blood 123 2014 2229 2237
67. D.C. Link, G. Kunter, and Y. Kasai Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia Blood 110 2007 1648 1655
68. R. Beekman, M.G. Valkhof, and M.A. Sanders Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia Blood 119 2012 5071 5077
69. K.C. Myers, A.A. Bolyard, and B. Otto Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry J Pediatr 164 2014 866 870
70. Y. Dror, P. Durie, and H. Ginzberg Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study Exp Hematol 30 2002 659 669
71. A. Minelli, E. Maserati, and E. Nicolis The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome Leukemia 23 2009 708 711
72. E. Maserati, B. Pressato, and R. Valli The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies Br J Haematol 145 2009 190 197